Exposure to environmental and lifestyle factors and attention-deficit/ hyperactivity disorder in children - A review of epidemiological studies

International Journal of Occupational Medicine and Environmental Health

Volumn 25, Issue 4, 2012, Pages 330-355

  Polańska, Kinga ^a   Jurewicz, Joanna ^a   Hanke, Wojciech ^a  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

Attention deficit hyperactivity disorder; Children; Environmental toxicants; Impulsivity; Inattention

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; BENZHYDRYL DERIVATIVE; FLUORINATED HYDROCARBON; PHENOL DERIVATIVE; PHTHALIC ACID DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON;

ATTENTION DEFICIT DISORDER; CHILD; DRINKING BEHAVIOR; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; LIFESTYLE; PASSIVE SMOKING; PREGNANCY; PRENATAL EXPOSURE; REVIEW;

ALCOHOL DRINKING; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BENZHYDRYL COMPOUNDS; CHILD; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; HYDROCARBONS, FLUORINATED; LIFE STYLE; PHENOLS; PHTHALIC ACIDS; POLYCYCLIC HYDROCARBONS, AROMATIC; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; TOBACCO SMOKE POLLUTION;

EID: 84874362185     PISSN: 12321087     EISSN: None     Source Type: Journal    
DOI: 10.2478/S13382-012-0048-0     Document Type: Review

References (105)

1. Polanczyk G, Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: A systematic review and metaregression analysis. Am J Psychiatry 2007;164:942-948.
2. Aguiar A, Eubig PA, Schantz SL. Attention deficit/hyperactivity disorder: A focused overview for children's environmental health researchers. Environ Health Perspect 2010;118(12):1646-1653.
3. Costello EJ, Mustillo S, Erkanli A, Keeler G, Angold A. Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry 2003;60(8):837-844.
4. Lesesne CA, Visser SN, White CP. Attention-deficit/hyperactivity disorder in school-aged children: association with maternal mental health and use of health care resources. Pediatrics 2003;111(5):1232-1237.
5. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M. Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Arch Gen Psychiatry 1993;50(7):565-576.
6. Braun JM, Kahn RS, Froehlich T, Auinger P, Lanphear BP. Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children. Environ Health Perspect 2006;114(12):1904-1909.
7. Masuo Y, Morita M, Oka S, Ishido M. Motor hyperactivity caused by a deficit in dopaminergic neurons and the effects of endocrine disruptors: A study inspired by the physiological roles of PACAP in the brain. Regul Pept 2004;15:225-234.
8. Ghisari M, Bonefeld-Jorgensen EC. Effects of plasticizers and their mixtures on estrogen receptor and thyroid hormone functions. Toxicol Lett 2009;189(1):67-77.
9. Huang PC, Kuo PL, Chou YY, Lin SJ, Lee CC. Association between prenatal exposure to phthalates and the health of newborns. Environ Int 2009;35(1):14-20.
10. Xu Y, Agrawal S, Cook TJ, Knipp GT. Di-(2-ethylhexyl)-phthalate affects lipid profiling in fetal rat brain upon maternal exposure. Arch Toxicol 2007;81(1):57-62.
11. Tanida T, Warita K, Ishihara K, Fukui S, Mitsuhashi T, Sugawara T, et al. Fetal and neonatal exposure to three typical environmental chemicals with different mechanisms of action: mixed exposure to phenol, phthalate, and dioxin cancels the effects of sole exposure on mouse midbrain dopaminergic nuclei. Toxicol Lett 2009;189(1):40-47.
12. Ishido M, Masuo Y, Kunimoto M, Oka S, Morita M. Bisphenol A causes hyperactivity in the rat concomitantly with impairment of tyrosine hydroxylase immunoreactivity. J Neurosci Res 2004;76(3):423-433.
13. Borch J, Metzdorff SB, Vinggaard AM, Brokken L, Dalgaard M. Mechanisms underlying the anti-androgenic effects of diethylhexyl phthalate in fetal rat testis. Toxicology 2006;223(1-2):144-155.
14. Ishido M, Masuo Y, Sayato-Suzuki J, Oka S, Niki E, Morita M. Dicyclohexylphthalate causes hyperactivity in the rat concomitantly with impairment of tyrosine hydroxylase immunoreactivity. J Neurochem 2004;91(1):69-76.
15. Engel SM, Zhu C, Berkowitz GS, Calafat AM, Silva MJ, Miodovnik A, Wolff MS. Prenatal phthalate exposure and performance on Neonatal Behavioral Assessment Scale in multiethnic birth cohort. Neurotoxicology 2009;30:522-528.
16. Engel SM, Miodovnik A, Canfield RL, Zhu C, Silva MJ, Calafat AM, et al. Prenatal phthalate exposure is associated with childhood behavior and executive functioning. Environ Health Perspect 2010;118(4):565-571.
17. Kim BN, Cho SC, Kim Y, Shin MS, Yoo HJ, Kim JW, et al. Phthalates exposure and attention-deficit/hyperactivity disorder in school-age children. Biol Psychiatry 2009;66(10):958-963.
18. Welshons WV, Nagel SC, vom Saal FS. Large effects from small exposures, part III: endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 2006;147(6 Suppl):56-69.
19. vom Saal FS, Akingbemi BT, Belcher SM, Birnbaum LS, Crain DA, Eriksen M, et al. Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol 2007;24(2):131-138.
20. Palanza P, Gioiosa L, vom Saal FS, Parmigiani S. Effects of developmental exposure to bisphenol A on brain and behavior in mice. Environ Res 2008;108(2):150-157.
21. Tian YH, Baek JH, Lee SY, Jang CG. Prenatal and postnatal exposure to bisphenol A induces anxiolytic behaviors and cognitive deficits in mice. Synapse 2010;64(6):432-439.
22. Palanza P, Morellini F, Parmigiani S, vom Saal FS. Prenatal exposure to endocrine disrupting chemicals: effects on behavioral development. Neurosci Biobehav Rev 1999;23(7): 1011-1027.
23. Braun JM, Yolton K, Dietrich KN, Horunung R, Ye X, Calafat AM, et al. Prenatal bisphenol A exposure and early childhood behavior. Environ Health Perspect 2009;117(12): 1945-1952.
24. Braun JM, Kalkbrenner AM, Calafat AM, Yolton K, Ye X, Dietrich KN, et al. Impact of Early-Life Bisphenol A exposure on behavior and executive function in children. Pediatrics 2011;128(5):873-882.
25. Longnecker MP. Human data on Bisphenol A and neurodevelopment. Environ Health Perspect 2009;117(12):531-532.
26. Hölling H, Kurth BM, Rothenberger A, Becker A, Schlack R. Assessing psychopathological problems of children and adolescents from 3 to 17 years in a nationwide representative sample: results of the German health interview and examination survey for children and adolescents (KiGGS). Eur Child Adolesc Psychiatry 2008;17(Suppl 1):34-41.
27. Stene-Larsen K, Borge AI, Vollrath ME. Maternal smoking in pregnancy and externalizing behavior in 18-month-old children: results from a population-based prospective study. J Am Acad Child Adolesc Psychiatry 2009;48:283-289.
28. Ryan BC, Vandenbergh JG. Developmental exposure to environmental estrogens alters anxiety and spatial memory in female mice. Horm Behav 2006;50:85-93.
29. Kuiper GG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 1998;139:4252-4263.
30. Calafat AM, Wong LY, Kuklenyik Z, Reidy JA, Needham LL. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect 2007;115:1596-1602.
31. Renner R. Growing concern over perfluorinated chemicals. Environ Sci Technol 2001;35(7):154-160.
32. Slotkin TA, MacKillop EA, Melnick RL, Thayer KA, Seidler FJ. Developmental neurotoxicity of perfluorinated chemicals modelled in vitro. Environ Health Perspect 2008;116: 716-722.
33. Johansson N, Fredriksson A, Eriksson P. Neonatal exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) causes neurobehavioural defects in adult mice. Neurotoxicology 2008;29(1):160-169.
34. Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: Postnatal evaluation. Toxicol Sci 2003;74(2):382-392.
35. Fuentes S, Vicens P, Colomina MT, Domingo JL. Behavioral effects in adult mice exposed to perfluorooctane sulfonate (PFOS). Toxicology 2007;242:123-129
36. Hoffman K, Webster TF, Weisskopf MG, Weinberg J, Vieira MV. Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in U.S. children 12-15 years of age. Environ Health Perspect 2010;118(12):1762-1767.
37. Fei C, McLaughlin JK, Lipworth L, Olsen J. Prenatal exposure to perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) and maternally reported developmental milestones in infancy. Environ Health Perspect 2008;116(10):1391-1395.
38. Perera FP, Wang S, Vishnevetsky J, Zhang B, Cole KJ, Tang D, et al. Polycyclic Aromatic Hydrocarbons-Aromatic DNA Adducts in Cord Blood and Behavior Scores in New York City Children. Environ Health Perspect 2011;119(8):1176- 1181.
39. Saunders CR, Das SK, Ramesh A, Shockley DC, Mukherjee S. Benzo(a)pyrene-induced acute neurotoxicity in the F-344 rat: role of oxidative stress. J Appl Toxicol 2006;26:427-438.
40. Šrám RJ, Binkova B. Molecular epidemiology studies on occupational and environmental exposure to mutagens and carcinogens, 1997-1999. Environ Health Perspect 2000;108:57-70.
41. Archibong AE, Inyang F, Ramesh A, Greenwood M, Nayyar T, Kopsombut P, et al. Alteration of pregnancy related hormones and fetal survival in F-344 rats exposed by inhalation to benzo(a)pyrene. Reprod Toxicol 2002;16:801-808.
42. Bui QQ, Tran MB, West WL. A comparative study of the reproductive effects of methadone and benzo(a)pyrene in the pregnant and pseudopregnant rat. Toxicol 1986;42(2-3): 195-204.
43. Takeda K, Tsukue N, Yoshida S. Endocrine-disrupting activity of chemicals in diesel exhaust and diesel exhaust particles. Environ Sci 2004;11:33-45.
44. Dejmek J, Solansky I, Beneš I, Lenícek J, Šrám RJ. The impact of polycyclic aromatic hydrocarbons and fine particles on pregnancy outcome. Environ Health Perspect 2000;108: 1159-1164.
45. Meyn MS. Ataxia-telangiectasia and cellular responses to DNA damage. Cancer Res 1995;55:5991-6001.
46. Nicol CJ, Harrison ML, Laposa RR, Gimelshtein IL, Wells PG. A teratologic suppressor role for p53 in benzo[a]pyrene-treated transgenic p53-deficient mice. Nat Genet 1995;10: 181-187.
47. Wood KA, Youle RJ. The role of free radicals and p53 in neuron apoptosis in vivo. J Neuroscience 1995;15:5851-5857.
48. Wilson VL, Jones PA. Inhibition of DNA methylation by chemical carcinogens in vitro. Cell 1983;32(1):239-246.
49. Lundqvist C, Zuurbier M, Leijs M, Johansson C, Ceccatelli S, Saunders M, et al. The effects of PCBs and dioxins on child health. Acta Paediatr 2006;453(Suppl 95):55-64.
50. Denson R, Nanson JL, McWatters MA. Hyperkinesis and maternal smoking. Can Psychiatr Assoc J 1975;20:183-187.
51. Linnet KM, Dalsgaard S, Obel C, Wisborg K, Henriksen TB, Rodriguez A, et al. Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am J Psychiatry 2003;160(6):1028-1040.
52. Banerjee TD, Middleton F, Faraone SV. Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatr 2007;96(9):1269-1274.
53. Nigg J, Nikolas M, Burt SA. Measured gene-by-environment interaction in relation to attention-deficit/hyperactivity disorder. J Amer Acad Child Adolesc Psychiatry 2010; 49: 863-873.
54. Button TM, Maughan B, McGuffin P. The relationship of maternal smoking to psychological problems in the offspring. Early Hum Dev 2007;83(11):727-732.
55. Froehlich TE, Anixt JS, Loe IM, Chirdkiatgumchai V, Kuan L, Gilman RC. Update on environmental risk factors for attention-deficit/hyperactivity disorder. Curr Psychiatry Rep 2011;13(5):333-344.
56. Huizink AC, Mulder EJ. Maternal smoking, drinking or cannabis use during pregnancy and neurobehavioral and cognitive functioning in human offspring. Neurosci Biobehav Rev 2006;30(1):24-41.
57. Hellström-Lindahl E, Seiger A, Kjaeldgaard A, Nordberg A. Nicotine-induced alterations in the expression of nicotinic receptors in primary cultures from human prenatal brain. Neurosci 2001;105(3):527-534.
58. Froehlich TE, Lanphear BP, Auinger P, Hornung R, Epstein JN, Braun J, et al. Association of tobacco and lead exposures with attention-deficit/ hyperactivity disorder. Pediatrics 2009;124(6):e1054-e1063.
59. Cho SC, Kim BN, Hong YC, Shin MS, Yoo HJ, Kim JW, et al. Effect of environmental exposure to lead and tobacco smoke on inattentive and hyperactive symptoms and neurocognitive performance in children. J Child Psychol Psychiatry 2010;51(9):1050-1057.
60. Rodriguez A, Bohlin G. Are maternal smoking and stress during pregnancy related to ADHD symptoms in children? J Child Psychol Psychiatry 2005;46(3):246-254.
61. Mick E, Biederman J, Faraone SV, Sayer J, Kleinman S. Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. J Am Acad Child Adolesc Psychiatry 2002;41(4): 378-385.
62. Button TM, Thapar A, McGuffin P. Relationship between antisocial behaviour, attention-deficit hyperactivity disorder and maternal prenatal smoking. Br J Psychiatry 2005;187:155-160.
63. Nomura Y, Marks DJ, Halperin JM. Prenatal Exposure to Maternal and Paternal Smoking on Attention Deficit Hyperactivity Disorders Symptoms and Diagnosis in Offspring. J Nerv Ment Dis 2010;198(9):672-678.
64. Motlagh MG, Katsovich L, Thompson N, Lin H, Kim YS, Scahill L, et al. Severe psychosocial stress and heavy cigarette smoking during pregnancy: an examination of the pre- and perinatal risk factors associated with ADHD and Tourette syndrome. Eur Child Adolesc Psychiatry 2010;19(10):755-764.
65. Hill SY, Lowers L, Locke-Wellman J, Shen SA. Maternal smoking and drinking during pregnancy and the risk for child and adolescent psychiatric disorders. J Stud Alcohol 2000; 61(5):661-668.
66. Nigg JT, Breslau N. Prenatal smoking exposure, low birth weight, and disruptive behavior disorders. J Am Acad Child Adolesc Psychiatry 2007;46(3):362-369.
67. Thapar A, Rice F, Hay D, Boivin J, Langley K, van den Bree M, et al. Prenatal smoking might not cause attention-deficit/hyperactivity disorder: evidence from a novel design. Biol Psychiatry 2009;66(8):722-727.
68. Lavigne JV, Hopkins J, Gouze KR, Bryant FB, LeBailly SA, Binns HJ, et al. Is Smoking During Pregnancy a Risk Factor for Psychopathology in Young Children? A Methodological Caveat and Report on Preschoolers. J Pediatr Psychol 2011;36(1): 10-24.
69. Markussen Linnet KM, Obel C, Bonde E, Hove Thomsen P, Secher NJ, Wisborg K, et al. Cigarette smoking during pregnancy and hyperactive-distractible preschoolers: a follow-up study. Acta Paediatr 2006;95(6):694-700.
70. Kotimaa AJ, Moilanen I, Taanila A, Ebeling H, Smalley SL, McGough JJ, et al. Maternal smoking and hyperactivity in 8-year-old children. J Am Acad Child Adolesc Psychiatry 2003;42(7):826-833.
71. Obel C, Linnet KM, Henriksen TB, Rodriguez A, Järvelin MR, Kotimaa A, et al. Smoking during pregnancy and hyperactivity-inattention in the offspring - comparing results from three Nordic cohorts. Int J Epidemiol 2009;38(3):698-705.
72. Huijbregts SC, Séguin JR, Zoccolillo M, Boivin M, Tremblay RE. Associations of maternal prenatal smoking with early childhood physical aggression, hyperactivity-impulsivity, and their co-occurrence. J Abnorm Child Psychol 2007;35(2): 203-215.
73. Romano E, Tremblay RE, Farhat A, Côté S. Development and prediction of hyperactive symptoms from 2 to 7 years in a population-based sample. Pediatrics 2006;117(6):2101-2110.
74. Day NL, Richardson GA, Goldschmidt L, Cornelius MD. Effects of prenatal tobacco exposure on preschoolers' behavior. J Dev Behav Pediatr 2000;21(3):180-188.
75. Höök B, Cederblad M, Berg R. Prenatal and postnatal maternal smoking as risk factors for preschool children's mental health. Acta Paediatr 2006;95(6):671-677.
76. Tremblay RE, Nagin DS, Séguin JR, Zoccolillo M, Zelazo PD, Boivin M, et al. Physical aggression during early childhood: trajectories and predictors. Pediatrics 2004;114(1):e43-e50.
77. Batstra L, Hadders-Algra M, Neeleman J. Effect of antenatal exposure to maternal smoking on behavioural problems and academic achievement in childhood: prospective evidence from a Dutch birth cohort. Early Hum Dev 2003;75(1-2):21-33.
78. D'Onofrio BM, Van Hulle CA, Waldman ID, Rodgers JL, Harden KP, Rathouz PJ, et al. Smoking during pregnancy and offspring externalizing problems: an exploration of genetic and environmental confounds. Dev Psychopathol 2008;20(1): 139-164.
79. Brion MJ, Victora C, Matijasevich A, Horta B, Anselmi L, Steer C, et al. Maternal smoking and child psychological problems: disentangling causal and noncausal effects. Pediatrics 2010;126(1):e57-e65.
80. Lindblad F, Hjern A. ADHD after fetal exposure to maternal smoking. Nicotine Tob Res 2010;12(4):408-415.
81. Bos-Veneman NG, Kuin A, Minderaa RB, Hoekstra PJ. Role of perinatal adversities on tic severity and symptoms of attention deficit/hyperactivity disorder in children and adolescents with a tic disorder. J Dev Behav Pediatr 2010;31(2):100-106.
82. Thapar A, Fowler T, Rice F, Scourfield J, van den Bree M, Thomas H, et al. Maternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring. Am J Psychiatry 2003;160(11):1985-1989.
83. Brook JS, Brook DW, Whiteman M. The influence of maternal smoking during pregnancy on the toddler's negativity. Arch Pediatr Adolesc Med 2000;154(4):381-385.
84. Brook DW, Zhang C, Rosenberg G, Brook JS. Maternal cigarette smoking during pregnancy and child aggressive behavior. Am J Addict 2006;15(6):450-456.
85. Ashford J, van Lier PA, Timmermans M, Cuijpers P, Koot HM. Prenatal smoking and internalizing and externalizing problems in children studied from childhood to late adolescence. J Am Acad Child Adolesc Psychiatry 2008;47(7): 779-787.
86. Knopik VS. Maternal smoking during pregnancy and child outcomes: real or spurious effect? Dev Neuropsychol 2009;34(1):1-36.
87. Kelly SJ, Day N, Streissguth AP. Effects of prenatal alcohol exposure on social behavior in humans and other species. Neurotoxicology and Teratology 2000;22:143-149.
88. Jacobson JJ, Jacobson SW. Effects of prenatal alcohol exposure on child development. Alcohol Research and Health 2002;26(4):282-286.
89. Bonthius DJ, West JR. Alcohol-induced neuronal loss in developing rats: increased brain damage with binge exposure. Alcohol Clin Exp Res 1990;14:107-118.
90. West JR, Goodlett CR, Bonthius DJ, Hamre KM, Marcussen BL. Cell population depletion associated with fetal alcohol brain damage: mechanisms of BAC-dependent cell loss. Alcohol Clin Exp Res 1990;14:813-818.
91. West JR, Kelly SI, Pierce DR. Severity of alcohol-induced deficits in rats during the first trimester equivalent is determined by the pattern of exposure. Alcohol 1987;Suppl 1:461-465.
92. Pratt OE. Introduction: what do we know of the mechanisms of alcohol damage in utero? Ciba Found Symp 1984;105:1-7.
93. Sood B, Delaney-Black V, Covington C, Nordstrom-Klee B, Ager J, Templin T, et al. Prenatal alcohol exposure and childhood behavior at age 6 to 7 years: I. Dose-Response effect. Pediatrics 2001;108:e34. DOI: 10.1542/peds.108.2.e34
94. Delaney-Black V, Covington C, Templin T, Ager J, Nordstrom-Klee B, Martier S, et al. Teacher-assessed behavior of children prenatally exposed to cocaine. Pediatrics 2000;106(4):782-791.
95. Nigg JT. What causes ADHD? Understanding what goes wrong and why? New York: The Guilford Press; 2006.
96. Bellinger DC. Late Neurodevelopmental Effects of Early Exposures to Chemical Contaminants: Reducing Uncertainty in Epidemiological Studies. Basic Clin Pharmacol Toxicol 2008;102:237-244.
97. Faraone SV, Biderman J, Milberger S. How reliable are maternal reports of their children's psychopathology? One-year recall of psychiatric diagnoses of ADHD children. J Am Acad Child Adolesc Psychiatry 1995;34(8):1001-1008.
98. Cohen S, Doyle WJ, Baum A. Socioeconomic status is associated with stress hormones. Psychosom Med 2006;68: 414-420.
99. Gallo LC, Matthews KA. Understanding the association between socioeconomic status and physical health: do negative emotions play a role? Psychol Bull 2003;129:10-51.
100. Hougaard KS, Hansen AM. Enhancement of developmental toxicity effects of chemicals by gestational stress: A review. Neurotoxicol Teratol 2007;29:425-445.
101. Biederman J, Mick E, Faraone SV, Braaten E, Doyle A, Spencer T, et al. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry 2002;159(1):36-42.
102. Newcorn JH, Halperin JM, Jensen PS, Abikoff HB, Arnold LE, Cantwell DP, et al. Symptom profiles in children with ADHD: Effects of comorbidity and gender. J Amer Acad Child Adolesc Psychiatry 2001;40:137-146.
103. Coe CL, Lulbach GR, Schneider ML. Prenatal disturbance alters the size of the corpus callosum in young monkeys. Dev Psychobiol 2002;41:178-85.
104. Staller J, Faraone SV. Attention-deficit hyperactivity disorder in girls: epidemiology and management. CNS Drugs 2006;20(2):107-123.
105. Hutchinson AD, Mathias JL, Banich MT. Corpus callosum morphology in children and adolescents with attention deficit hyperactivity disorder: A meta-analytic review. Neuropsychology 2008;22(3):341-349.